The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of costs incurred by patients treated with adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma.
 
Xin Yin
Employment - Bristol-Myers Squibb; Merck
Research Funding - Bristol-Myers Squibb
 
Shreya Mitra
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Miraj Y Patel
Employment - Bristol-Myers Squibb/Medarex; CVS Health (I); LEO Pharma; Pfizer (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb/Medarex; CVS Health (I); Sanofi
 
Sandip Ranjan
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Janssen (Inst); Pfizer (Inst); Sanofi (Inst)
 
Hitesh Bhandari
Employment - SmartAnalyst
Research Funding - Boehringer Ingelheim (Inst); Bristol Myers Squibb (Inst); Helsinn Therapeutics (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Sanofi (Inst)
 
Ravi Potluri
Employment - SmartAnalyst
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Cytokinetics (Inst); Geron (Inst); Helsinn Therapeutics (Inst); Janssen (Inst); Pfizer (Inst); SERVIER (Inst)
 
Lisa Rosenblatt
Employment - Bristol Myers Squibb
Stock and Other Ownership Interests - Bristol Myers Squibb
Travel, Accommodations, Expenses - Bristol Myers Squibb